TEICOPLANIN MEDICIANZ (Medicianz Healthcare Pty Ltd)
Product name
TEICOPLANIN MEDICIANZ
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
137 (255 working days)
Active ingredients
teicoplanin
Registration type
New generic medicine
Indication
Teicoplanin is indicated for the treatment of the following infections due to staphylococci or streptococci, which cannot be treated satisfactorily with less toxic agents, including B-lactam antibiotics:
Bone – osteomyelitis
Joints - septic arthritis
Blood - non-cardiac bacteraemia, septicaemia.